Modeling and Predicting Tumor Response in Radioligand Therapy

Peter Kletting; Anne Thieme; Nina Eberhardt; Andreas Rinscheid; Calogero D’Alessandria; Jakob Allmann; Hans-Jürgen Wester; Robert Tauber; Ambros J. Beer; Gerhard Glatting; Matthias Eiber

doi:10.2967/jnumed.118.210377

Research ArticleTheranostics

Modeling and Predicting Tumor Response in Radioligand Therapy

Peter Kletting, Anne Thieme, Nina Eberhardt, Andreas Rinscheid, Calogero D’Alessandria, Jakob Allmann, Hans-Jürgen Wester, Robert Tauber, Ambros J. Beer, Gerhard Glatting and Matthias Eiber

Journal of Nuclear Medicine January 2019, 60 (1) 65-70; DOI: https://doi.org/10.2967/jnumed.118.210377

Peter Kletting

1Department of Nuclear Medicine, Ulm University, Ulm, Germany

2Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne Thieme

3Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nina Eberhardt

1Department of Nuclear Medicine, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Rinscheid

1Department of Nuclear Medicine, Ulm University, Ulm, Germany

2Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Calogero D’Alessandria

3Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jakob Allmann

3Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hans-Jürgen Wester

4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Tauber

5Department of Urology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ambros J. Beer

1Department of Nuclear Medicine, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerhard Glatting

1Department of Nuclear Medicine, Ulm University, Ulm, Germany

2Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

3Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 1

January 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Modeling and Predicting Tumor Response in Radioligand Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Modeling and Predicting Tumor Response in Radioligand Therapy

Peter Kletting, Anne Thieme, Nina Eberhardt, Andreas Rinscheid, Calogero D’Alessandria, Jakob Allmann, Hans-Jürgen Wester, Robert Tauber, Ambros J. Beer, Gerhard Glatting, Matthias Eiber

Journal of Nuclear Medicine Jan 2019, 60 (1) 65-70; DOI: 10.2967/jnumed.118.210377

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Modeling and Predicting Tumor Response in Radioligand Therapy

Peter Kletting, Anne Thieme, Nina Eberhardt, Andreas Rinscheid, Calogero D’Alessandria, Jakob Allmann, Hans-Jürgen Wester, Robert Tauber, Ambros J. Beer, Gerhard Glatting, Matthias Eiber

Journal of Nuclear Medicine Jan 2019, 60 (1) 65-70; DOI: 10.2967/jnumed.118.210377

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
Combination Strategies to Improve Targeted Radionuclide Therapy
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

Google Scholar

Theranostics

¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy
Terbium-161, a Promising New Theranostic Radionuclide

Show more Theranostics

Translational

Imaging Diverse Pathogenic Bacteria In Vivo with ¹⁸F-Fluoromannitol PET
Modeling Early Radiation DNA Damage Occurring During ¹⁷⁷Lu-DOTATATE Radionuclide Therapy
First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer

Show more Translational

Keywords

PBPK/PD model
radioligand therapy
177Lu-PSMA
Tumor Response

Main menu

User menu

Search

Modeling and Predicting Tumor Response in Radioligand Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Translational

Similar Articles

Keywords